155 related articles for article (PubMed ID: 23149414)
1. Vitamin D directly regulates Mdm2 gene expression in osteoblasts.
Chen H; Reed G; Guardia J; Lakhan S; Couture O; Hays E; Chandar N
Biochem Biophys Res Commun; 2013 Jan; 430(1):370-4. PubMed ID: 23149414
[TBL] [Abstract][Full Text] [Related]
2. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
3. p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours.
Dimitriadi M; Poulogiannis G; Liu L; Bäcklund LM; Pearson DM; Ichimura K; Collins VP
Br J Cancer; 2008 Oct; 99(7):1144-52. PubMed ID: 18781178
[TBL] [Abstract][Full Text] [Related]
4. MDM2 binds and inhibits vitamin D receptor.
Heyne K; Heil TC; Bette B; Reichrath J; Roemer K
Cell Cycle; 2015; 14(13):2003-10. PubMed ID: 25969952
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
Liang H; Lunec J
Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
7. p53 and MDM2 are involved in the regulation of osteocalcin gene expression.
Chen H; Kolman K; Lanciloti N; Nerney M; Hays E; Robson C; Chandar N
Exp Cell Res; 2012 May; 318(8):867-76. PubMed ID: 22405968
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
9. Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
[TBL] [Abstract][Full Text] [Related]
10. Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts.
Daniele S; Giacomelli C; Pietrobono D; Barresi E; Piccarducci R; La Pietra V; Taliani S; Da Settimo F; Marinelli L; Novellino E; Martini C; Trincavelli ML
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):737-749. PubMed ID: 30703414
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
[TBL] [Abstract][Full Text] [Related]
12. The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.
González-Duarte RJ; Cázares-Ordoñez V; Díaz L; Ortíz V; Larrea F; Avila E
Mol Cell Biochem; 2015 Dec; 410(1-2):65-73. PubMed ID: 26314252
[TBL] [Abstract][Full Text] [Related]
13. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
15. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.
Kim S; Yamazaki M; Zella LA; Shevde NK; Pike JW
Mol Cell Biol; 2006 Sep; 26(17):6469-86. PubMed ID: 16914732
[TBL] [Abstract][Full Text] [Related]
16. Regulation of expression of the rat orthologue of mouse double minute 2 (MDM2) by H(2)O(2)-induced oxidative stress in neonatal rat cardiac myocytes.
Pikkarainen S; Kennedy RA; Marshall AK; Tham el L; Lay K; Kriz TA; Handa BS; Clerk A; Sugden PH
J Biol Chem; 2009 Oct; 284(40):27195-210. PubMed ID: 19638633
[TBL] [Abstract][Full Text] [Related]
17. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
[TBL] [Abstract][Full Text] [Related]
18. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells.
Du H; Daftary GS; Lalwani SI; Taylor HS
Mol Endocrinol; 2005 Sep; 19(9):2222-33. PubMed ID: 15905361
[TBL] [Abstract][Full Text] [Related]
19. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
20. 1α,25-dihydroxyvitamin D₃ rapidly modulates Ca(2+) influx in osteoblasts mediated by Ca(2+) channels.
Uchida Y; Endoh T; Shibukawa Y; Tazaki M; Sueishi K
Bull Tokyo Dent Coll; 2010; 51(4):221-6. PubMed ID: 21139376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
